you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Dec 03, 16:00
4924.50 75.15 (1.55%)
Volume
AVERAGE VOLUME
5-Day
46,032
10-Day
51,068
30-Day
57,555
67,038
  • Prev. Close

    4849.35

  • Open Price

    4853.30

  • Bid Price (Qty.)

    4924.50 (58)

  • Offer Price (Qty.)

    4945.00 (25)

NSE Live

Dec 03, 15:58
4923.05 72.80 (1.50%)
Volume
AVERAGE VOLUME
5-Day
1,409,302
10-Day
1,650,275
30-Day
1,699,178
1,034,893
  • Prev. Close

    4850.25

  • Open Price

    4870.00

  • Bid Price (Qty.)

    4923.05 (1259)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2019 2018 2017 2016 2015
Nine Months Results of Dr Reddys Laboratories (in Rs. Cr.) Dec '19 Dec '18 Dec '17 Dec '16 Dec '15  
Net Sales/Income from operations 8,972.70 7,858.30 6,826.00 7,324.70 7,867.00  
Other Operating Income 26.00 122.00 41.00 35.00 46.50  
Total Income From Operations 8,998.70 7,980.30 6,867.00 7,359.70 7,913.50  
EXPENDITURE  
Consumption of Raw Materials 1,902.20 1,579.90 1,437.00 1,434.60 1,560.90  
Purchase of Traded Goods 891.10 632.10 457.00 502.90 483.70  
Increase/Decrease in Stocks -167.10 -40.30 -12.70 -167.20 -74.90  
Power & Fuel -- -- -- -- --  
Employees Cost 1,513.60 1,441.90 1,379.70 1,431.00 1,261.20  
Depreciation 596.90 576.40 584.10 545.50 468.30  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- 800.70 759.70 771.70  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 2,510.10 2,503.60 1,801.80 1,963.90 1,877.90  
P/L Before Other Inc. , Int., Excpt. Items & Tax 1,751.90 1,286.70 419.40 889.30 1,564.70  
Other Income 615.80 165.70 130.90 533.20 226.30  
P/L Before Int., Excpt. Items & Tax 2,367.70 1,452.40 550.30 1,422.50 1,791.00  
Interest 36.00 48.10 48.70 41.40 49.50  
P/L Before Exceptional Items & Tax 2,331.70 1,404.30 501.60 1,381.10 1,741.50  
Exceptional Items -- -- -- -- --  
P/L Before Tax 2,331.70 1,404.30 501.60 1,381.10 1,741.50  
Tax -103.20 329.80 111.30 220.00 328.50  
P/L After Tax from Ordinary Activities 2,434.90 1,074.50 390.30 1,161.10 1,413.00  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 2,434.90 1,074.50 390.30 1,161.10 1,413.00  
Equity Share Capital 83.10 83.00 82.90 82.90 85.30  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 146.89 64.75 23.54 69.55 82.86  
Diluted EPS 146.62 64.67 23.49 69.38 82.60  
EPS After Extra Ordinary  
Basic EPS. 146.89 64.75 23.54 69.55 82.86  
Diluted EPS. 146.62 64.67 23.49 69.38 82.60  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs